Extracellular annexin A5: Functions of phosphatidylserine-binding and two-dimensional crystallization

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 6, 2008, Pages 953-963

  van Genderen, Hugo O ^a   Kenis, Heidi ^a   Hofstra, Leo ^a   Narula, Jagat ^b   Reutelingsperger, Chris P M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Annexin A5; Endocytosis; Exocytosis; Microparticle; Phosphatidylserine; Plasma membrane

Indexed keywords

BLOOD CLOTTING FACTOR 10A; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

APOPTOSIS; BLOOD CLOTTING; CELL MEMBRANE; CRYSTALLIZATION; ENDOCYTOSIS; HUMAN; LEUKOCYTE; MEMBRANE BINDING; MEMBRANE MICROPARTICLE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; THROMBOCYTE ACTIVATION;

ANNEXIN A5; APOPTOSIS; CELL MEMBRANE; CRYSTALLIZATION; HUMANS; PHAGOCYTOSIS; PHOSPHATIDYLSERINES;

EID: 43549116086     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.01.030     Document Type: Review

References (122)

1. 2+ signaling to membrane dynamics. Nat. Rev., Mol. Cell Biol. 6 6 (2005) 449-461
2. 2+-binding protein p68 a novel member of a protein family. EMBO J. 7 1 (1988) 21-27
3. Boersma H.H., Kietselaer B.L., Stolk L.M., Bennaghmouch A., Hofstra L., Narula J., Heidendal G.A., and Reutelingsperger C.P. Past, present, and future of annexin A5: from protein discovery to clinical applications. J. Nucl. Med. 46 (2005) 2035-2050
4. Andree H.A., Reutelingsperger C.P., Hauptmann R., Hemker H.C., Hermens W.T., and Willems G.M. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J. Biol. Chem. 265 9 (1990) 4923-4928
5. Huber R., Romisch J., and Paques E.P. The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes. EMBO J. 9 12 (1990) 3867-3874
6. Huber R., Schneider M., Mayr I., Romisch J., and Paques E.P. The calcium binding sites in human annexin V by crystal structure analysis at 2.0 Å resolution. Implications for membrane binding and calcium channel activity. FEBS Lett. 275 1-2 (1990) 15-21
7. Meers P., and Mealy T. Relationship between annexin V tryptophan exposure, calcium, and phospholipid binding. Biochemistry 32 20 (1993) 5411-5418
8. Oling F., Santos J.S., Govorukhina N., Mazeres-Dubut C., Bergsma-Schutter W., Oostergetel G., Keegstra W., Lambert O., Lewit-Bentley A., and Brisson A. Structure of membrane-bound annexin A5 trimers: a hybrid cryo-EM - X-ray crystallography study. J. Mol. Biol. 304 4 (2000) 561-573
9. Reviakine I., Bergsma-Schutter W., and Brisson A. Growth of protein 2-D crystals on supported planar lipid bilayers imaged in situ by AFM. J. Struct. Biol. 121 3 (1998) 356-361
10. Olofsson A., Mallouh V., and Brisson A. Two-dimensional structure of membrane-bound annexin V at 8 Å resolution. J. Struct. Biol. 113 3 (1994) 199-205
11. Oling F., Bergsma-Schutter W., and Brisson A. Trimers, dimers of trimers, and trimers of trimers are common building blocks of annexin a5 two-dimensional crystals. J. Struct. Biol. 133 1 (2001) 55-63
12. Richter R.P., Him J.L., Tessier B., Tessier C., and Brisson A.R. On the kinetics of adsorption and two-dimensional self-assembly of annexin A5 on supported lipid bilayers. Biophys. J. 89 (2005) 3372-3385
13. Tait J.F., Gibson D.F., and Smith C. Measurement of the affinity and cooperativity of annexin V-membrane binding under conditions of low membrane occupancy. Anal. Biochem. 329 1 (2004) 112-119
14. Stuart M.C., Reutelingsperger C.P., and Frederik P.M. Binding of annexin V to bilayers with various phospholipid compositions using glass beads in a flow cytometer. Cytometry 33 4 (1998) 414-419
15. Rink L., and Kirchner H. Zinc-altered immune function and cytokine production. J. Nutr. 130 5S (2000) 1407S-1411S
16. Vergnolle N., Pages P., Guimbaud R., Chaussade S., Bueno L., Escourrou J., and Comera C. Annexin 1 is secreted in situ during ulcerative colitis in humans. Inflamm. Bowel Dis. 10 5 (2004) 584-592
17. Danielsen E.M., van Deurs B., and Hansen G.H. "Nonclassical" secretion of annexin A2 to the lumenal side of the enterocyte brush border membrane. Biochemistry 42 49 (2003) 14670-14676
18. Masuda J., Takayama E., Satoh A., Ida M., Shinohara T., Kojima-Aikawa K., Ohsuzu F., Nakanishi K., Kuroda K., Murakami M., Suzuki K., and Matsumoto I. Levels of annexin IV and V in the plasma of pregnant and postpartum women. Thromb. Haemost. 91 6 (2004) 1129-1136
19. Romisch J., Schuler E., Bastian B., Burger T., Dunkel F.G., Schwinn A., Hartmann A.A., and Paques E.P. Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coagul. Fibrinolysis 3 1 (1992) 11-17
20. Kaneko N., Matsuda R., Hosoda S., Kajita T., and Ohta Y. Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction. Clin. Chim. Acta. 251 1 (1996) 65-80
21. Martoglio B., and Dobberstein B. Signal sequences: more than just greasy peptides. Trends Cell Biol. 8 10 (1998) 410-415
22. Hamon Y., Luciani M.F., Becq F., Verrier B., Rubartelli A., and Chimini G. Interleukin-1beta secretion is impaired by inhibitors of the ATP binding cassette transporter, ABC1. Blood 90 8 (1997) 2911-2915
23. Andrei C., Margiocco P., Poggi A., Lotti L.V., Torrisi M.R., and Rubartelli A. Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: implications for inflammatory processes. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9745-9750
24. Carta S., Tassi S., Semino C., Fossati G., Mascagni P., Dinarello C.A., and Rubartelli A. Histone deacetylase inhibitors prevent exocytosis of interleukin-1β-containing secretory lysosomes: role of microtubules. Blood 108 (2006) 1618-1626
25. Qu Y., Franchi L., Nunez G., and Dubyak G.R. Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J. Immunol. 179 (2007) 1913-1925
26. MacKenzie A., Wilson H.L., Kiss-Toth E., Dower S.K., and North R.A. Surprenant A. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15 5 (2001) 825-835
27. Hughes R.C. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim. Biophys. Acta 1473 1 (1999) 172-185
28. Prudovsky I., Mandinova A., Soldi R., Bagala C., Graziani I., Landriscina M., Tarantini F., Duarte M., Bellum S., Doherty H., and Maciag T. The non-classical export routes: FGF1 and IL-1alpha point the way. J. Cell Sci. 116 24 (2003) 4871-4881
29. Schafer T., Zentgraf H., Zehe C., Brugger B., Bernhagen J., and Nickel W. Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J. Biol. Chem. 279 8 (2004) 6244-6251
30. Backhaus R., Zehe C., Wegehingel S., Kehlenbach A., Schwappach B., and Nickel W. Unconventional protein secretion: membrane translocation of FGF-2 does not require protein unfolding. J. Cell Sci. 117 9 (2004) 1727-1736
31. Zehe C., Engling A., Wegehingel S., Schafer T., and Nickel W. Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2. Proc. Natl. Acad. Sci. U. S. A. 103 42 (2006) 15479-15484
32. Perretti M., Croxtall J.D., Wheller S.K., Goulding N.J., Hannon R., and Flower R.J. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat. Med. 2 11 (1996) 1259-1262
33. Gavins F.N., Yona S., Kamal A.M., Flower R.J., and Perretti M. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 101 10 (2003) 4140-4147
34. Hayhoe R.P., Kamal A.M., Solito E., Flower R.J., Cooper D., and Perretti M. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 107 5 (2006) 2123-2130
35. Chapman L., Nishimura A., Buckingham J.C., Morris J.F., and Christian H.C. Externalization of annexin I from a folliculo-stellate-like cell line. Endocrinology 143 11 (2002) 4330-4338
36. Philip J.G., Flower R.J., and Buckingham J.C. Blockade of the classical pathway of protein secretion does not affect the cellular exportation of lipocortin 1. Regul. Pept. 73 2 (1998) 133-139
37. Solito E., Mulla A., Morris J.F., Christian H.C., Flower R.J., and Buckingham J.C. Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. Endocrinology 144 4 (2003) 1164-1174
38. Chapman L.P., Epton M.J., Buckingham J.C., Morris J.F., and Christian H.C. Evidence for a role of the adenosine 5′-triphosphate-binding cassette transporter A1 in the externalization of annexin I from pituitary folliculo-stellate cells. Endocrinology 144 3 (2003) 1062-1073
39. Hajjar K.A., Jacovina A.T., and Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J. Biol. Chem. 269 33 (1994) 21191-21197
40. Ling Q., Jacovina A.T., Deora A., Febbraio M., Simantov R., Silverstein R.L., Hempstead B., Mark W.H., and Hajjar K.A. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J. Clin. Invest. 113 1 (2004) 38-48
41. Peterson E.A., Sutherland M.R., Nesheim M.E., and Pryzdial E.L. Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2. J. Cell Sci. 116 12 (2003) 2399-2408
42. Deora A.B., Kreitzer G., Jacovina A.T., and Hajjar K.A. An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J. Biol. Chem. 279 42 (2004) 43411-43418
43. Krikun G., Lockwood C.J., Wu X.X., Zhou X.D., Guller S., Calandri C., Guha A., Nemerson Y., and Rand J.H. The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta 15 6 (1994) 601-612
44. Monceau V., Belikova Y., Kratassiouk G., Charue D., Camors E., Communal C., Trouve P., Russo-Marie F., and Charlemagne D. Externalization of endogenous annexin A5 participates in apoptosis of rat cardiomyocytes. Cardiovasc. Res. 64 3 (2004) 496-506
45. Ravassa S., Bennaghmouch A., Kenis H., Lindhout T., Hackeng T., Narula J., Hofstra L., and Reutelingsperger C. Annexin A5 down-regulates surface expression of tissue factor: a novel mechanism of regulating the membrane receptor repertoire. J. Biol. Chem. 280 7 (2005) 6028-6035
46. Balasubramanian K., and Schroit A.J. Aminophospholipid asymmetry: a matter of life and death. Annu. Rev. Physiol. 65 (2003) 701-734
47. Yeung T., Gilbert G.E., Shi J., Silvius J., Kapus A., and Grinstein S. Membrane phosphatidylserine regulates surface charge and protein localization. Science 319 (2008) 210-213
48. Heemskerk J.W., Bevers E.M., and Lindhout T. Platelet activation and blood coagulation. Thromb. Haemost. 88 2 (2002) 186-193
49. Zwaal R.F., Comfurius P., and Bevers E.M. Surface exposure of phosphatidylserine in pathological cells. Cell. Mol. Life Sci. 62 9 (2005) 971-988
50. Callahan M.K., Halleck M.S., Krahling S., Henderson A.J., Williamson P., and Schlegel R.A. Phosphatidylserine expression and phagocytosis of apoptotic thymocytes during differentiation of monocytic cells. J. Leukoc. Biol. 74 5 (2003) 846-856
51. Elliott J.I., Surprenant A., Marelli-Berg F.M., Cooper J.C., Cassady-Cain R.L., Wooding C., Linton K., Alexander D.R., and Higgins C.F. Membrane phosphatidylserine distribution as a nonapoptotic signaling mechanism in lymphocytes. Nat. Cell Biol. 7 (2005) 808-816
52. Dias-Baruffi M., Zhu H., Cho M., Karmakar S., McEver R.F., and Cummings R.D. Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis. J. Biol. Chem. 278 42 (2003) 41282-41293
53. Stowell S.R., Karmakar S., Stowell C.J., Dias-Baruffi M., McEver R.F., and Cummings R.D. Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells. Blood 109 1 (2007) 219-227
54. Lyden T.W., Ng A.K., and Rote N.S. Modulation of phosphatidylserine epitope expression by BeWo cells during forskolin treatment. Placenta 14 2 (1993) 177-186
55. Rote N.S., Chang J., Katsuragawa H., Ng A.K., Lyden T.W., and Mori T. Expression of phosphatidylserine-dependent antigens on the surface of differentiating BeWo human choriocarcinoma cells. Am. J. Reprod. Immunol. 33 1 (1995) 114-121
56. van den Eijnde S.M., van den Hoff M.J., Reutelingsperger C.P., van Heerde W.L., Henfling M.E., Vermeij-Keers C., Schutte B., Borgers M., and Ramaekers F.C. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J. Cell Sci. 114 (2001) 3631-3642
57. Dillon S.R., Constantinescu A., and Schlissel M.S. Annexin V binds to positively selected B cells. J. Immunol. 166 (2001) 58-71
58. Elliott J.I., Sardini A., Cooper J.C., Alexander D.R., Davanture S., Chimini G., and Higgins C.F. Phosphatidylserine exposure in B lymphocytes: a role for lipid packing. Blood 108 5 (2006) 1611-1617
59. Williamson P., and Schlegel R.A. Transbilayer phospholipid movement and the clearance of apoptotic cells. Biochim. Biophys. Acta 1585 2-3 (2002) 53-63
60. Tang X., Halleck M.S., Schlegel R.A., and Williamson P. A subfamily of P-type ATPases with aminophospholipid transporting activity. Science 272 5267 (1996) 1495-1497
61. Zhou Q., Zhao J., Stout J.G., Luhm R.A., Wiedmer T., and Sims P.J. Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J. Biol. Chem. 272 29 (1997) 18240-18244
62. Wiedmer T., Zhou Q., Kwoh D.Y., and Sims P.J. Identification of three new members of the phospholipid scramblase gene family. Biochim. Biophys. Acta 1467 1 (2000) 244-253
63. Zhou Q., Zhao J., Wiedmer T., and Sims P.J. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood 99 11 (2002) 4030-4038
64. Dekkers D.W., Comfurius P., Schroit A.J., Bevers E.M., and Zwaal R.F. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry 37 42 (1998) 14833-14837
65. Kamp D., and Haest C.W. Evidence for a role of the multidrug resistance protein (MRP) in the outward translocation of NBD-phospholipids in the erythrocyte membrane. Biochim. Biophys. Acta 1372 1 (1998) 91-101
66. Züllig S., Neukomm L.J., Jovanovic M., Charette S.J., Lyssenko N.N., Halleck M.S., Reutelingsperger C.P., Schlegel R.A., and Hengartner M.O. Aminophospholipid translocase TAT-1 promotes phosphatidylserine exposure during C. elegans apoptosis. Curr. Biol. 17 11 (2007) 994-999
67. Wolfs J.L., Comfurius P., Rasmussen J.T., Keuren J.F., Lindhout T., Zwaal R.F., and Bevers E.M. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction. Cell. Mol. Life Sci. 62 (2005) 1514-1525
68. Verhoven B., Schlegel R.A., and Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182 (1995) 1597-1601
69. Martin S.J., Finucane D.M., Amarante-Mendes G.P., O'Brien G.A., and Green D.R. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem 271 (1996) 28753-28756
70. Foghsgaard L., Wissing D., Mauch D., Lademann U., Bastholm L., Boes M., Elling F., Leist M., and Jaattela M. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153 (2001) 999-1010
71. Balasubramanian K., Mirnikjoo B., and Schroit A.J. Regulated externalization of phosphatidylserine at the cell surface: Implications for apoptosis. J. Biol. Chem. 282 25 (2007) 18357-18364
72. Miyanishi M., Tada K., Koike M., Uchiyama Y., Kitamura T., and Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature 450 (2007) 435-439
73. Reutelingsperger C.P., Hornstra G., and Hemker H.C. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur. J. Biochem. 151 3 (1985) 625-629
74. Reutelingsperger C.P., Kop J.M., Hornstra G., and Hemker H.C. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids. Eur. J. Biochem. 173 1 (1988) 171-178
75. Sim D., Flaumenhaft R., Furie B., and Furie B. Interactions of platelets, blood-borne tissue factor, and fibrin during arteriolar thrombus formation in vivo. Microcirculation 12 3 (2005) 301-311
76. Monroe D.M., Hoffman M., and Roberts H.R. Platelets and thrombin generation. Arterioscler. Thromb. Vasc. Biol. 22 9 (2002) 1381-1389
77. Lane D.A., Philippou H., and Huntington J.A. Directing thrombin. Blood. 106 8 (2005) 2605-2612
78. Lord S.T. Fibrinogen and fibrin: scaffold proteins in hemostasis. Curr. Opin. Hematol. 14 3 (2007) 236-241
79. van Heerde W.L., Poort S., van 't Veer C., Reutelingsperger C.P., and de Groot P.G. Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation. Biochem. J. 302 1 (1994) 305-312
80. Andree H.A., Stuart M.C., Hermens W.T., Reutelingsperger C.P., Hemker H.C., Frederik P.M., and Willems G.M. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J. Biol. Chem. 267 25 (1992) 17907-17912
81. Rand J.H., Wu X.X., Andree H.A., Lockwood C.J., Guller S., Scher J., and Harpel P.C. Pregnancy loss in the antiphospholipid-antibody syndrome, a possible thrombogenic mechanism. N. Engl. J. Med. 337 3 (1997) 154-160
82. Gude N.M., Roberts C.T., Kalionis B., and King R.G. Growth and function of the normal human placenta. Thromb. Res. 114 5-6 (2004) 397-407
83. Rand J.H., Wu X.X., Quinn A.S., Chen P.P., McCrae K.R., Bovill E.G., and Taatjes D.J. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am. J. Pathol. 163 3 (2003) 1193-1200
84. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 353 9161 (1999) 1348-1353
85. Kroemer G., El-Deiry W.S., Golstein P., Peter M.E., Vaux D., Vandenabeele P., Zhivotovsky B., Blagosklonny M.V., Malorni W., Knight R.A., Piacentini M., Nagata S., and Melino G. Nomenclature Committee on Cell Death. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ. 12 2 (2005) 1463-1467 9
86. Hengartner M.O. The biochemistry of apoptosis. Nature 407 6805 (2000) 770-776
87. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., and Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148 7 (1992) 2207-2216
88. Coleman M.L., Sahai E.A., Yeo M., Bosch M., Dewar A., and Olson M.F. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3 4 (2001) 339-345
89. Savill J., Dransfield I., Gregory C., and Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2 (2002) 965-975
90. Munoz L.E., Frey B., Pausch F., Baum W., Mueller R.B., Brachvogel B., Poschl E., Rödel F., von der Mark K., Herrmann M., and Gaipl U.S. The role of annexin A5 in the modulation of the immune response against dying and dead cells. Curr. Med. Chem. 14 3 (2007) 271-277
91. Henson P.M., Bratton D.L., and Fadok V.A. The phosphatidylserine receptor: a crucial molecular switch?. Nat. Rev., Mol. Cell Biol. 2 (2001) 627-633
92. Hanayama R., Tanaka M., Miwa K., Shinohara A., Iwamatsu A., and Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 417 (2002) 182-187
93. Maiti S.N., Balasubramanian K., Ramoth J.A., and Schroit A.J. Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells: Binding to LRP receptor family members. J. Biol. Chem. 15 283 (2008) 3761-3766
94. Fan X., Krahling S., Smith D., Williamson P., and Schlegel R.A. Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes. Mol. Biol. Cell 15 6 (2004) 2863-2872
95. Kenis H., van Genderen H., Deckers N.M., Lux P.A., Hofstra L., Narula J., and Reutelingsperger C.P. Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches. Exp. Cell. Res. 312 6 (2006) 719-726
96. Munoz L.E., Franz S., Pausch F., Fürnrohr B., Sheriff A., Vogt B., Kern P.M., Baum W., Stach C., von Laer D., Brachvogel B., Poschl E., Herrmann M., and Gaipl U.S. The influence on the immunomodulatory effects of dying and dead cells of Annexin V. J. Leukoc. Biol. 81 1 (2007) 6-14
97. Gidon-Jeangirard C., Hugel B., Holl V., Toti F., Laplanche J.L., Meyer D., and Freyssinet J.M. Annexin V delays apoptosis while exerting an external constraint preventing the release of CD4+ and PrPc+ membrane particles in a human T lymphocyte model. J. Immunol. 162 10 (1999) 5712-5718
98. Kenis H., van Genderen H., Bennaghmouch A., Rinia H.A., Frederik P., Narula J., Hofstra L., and Reutelingsperger C.P. Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J. Biol. Chem. 279 50 (2004) 52623-52629
99. Hugel B., Martinez M.C., Kunzelmann C., and Freyssinet J.M. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 20 (2005) 22-27
100. George J.N., Thoi L.L., McManus L.M., and Reimann T.A. Isolation of human platelet membrane microparticles from plasma and serum. Blood 60 (1982) 834-840
101. Ardoin S.P., Shanahan J.C., and Pisetsky D.S. The role of microparticles in inflammation and thrombosis. Scand. J. Immunol. 66 (2007) 159-165
102. Martinez M.C., Larbret F., Zobairi F., Coulombe J., Debili N., Vainchenker W., Ruat M., and Freyssinet J.M. Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens. Blood 108 (2006) 3012-3020
103. Fritzsching B., Schwer B., Kartenbeck J., Pedal A., Horejsi V., and Ott M. Release and intercellular transfer of cell surface CD81 via microparticles. J. Immunol. 169 10 (2002) 5531-5537
104. Falati S., Liu Q., Gross P., Merrill-Skoloff G., Chou J., Vandendries E., Celi A., Croce K., Furie B.C., and Furie B. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J. Exp. Med. 197 11 (2003) 1585-1598
105. Hrachovinova I., Cambien B., Hafezi-Moghadam A., Kappelmayer J., Camphausen R.T., Widom A., Xia L., Kazazian H.H., Schaub R.G., McEver R.P., and Wagner D.D. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat. Med. 9 8 (2003) 1020-1025
106. Del Conde I., Shrimpton C.N., Thiagarajan P., and Lopez J.A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 106 5 (2005) 1604-1611
107. D.L. Sprague, B.D. Elzey, S.A. Crist, T.J. Waldschmidt, R.J. Jensen, T.L. Ratliff, Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. (in press) (2008 Jan 15, Electronic publication ahead of print).
108. Mack M., Kleinschmidt A., Bruhl H., Klier C., Nelson P.J., Cihak J., Plachy J., Stangassinger M., Erfle V., and Schlondorff D. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat. Med. 6 7 (2000) 769-775
109. Giesen P.L., Rauch U., Bohrmann B., Kling D., Roque M., Fallon J.T., Badimon J.J., Himber J., Riederer M.A., and Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2311-2315
110. Mallat Z., Hugel B., Ohan J., Leseche G., Freyssinet J.M., and Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99 (1999) 348-353
111. Thiagarajan P., and Tait J.F. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J. Biol. Chem. 266 (1991) 24302-24307
112. 2+-ATPase inhibitors. Biochemistry 34 36 (1995) 11625-11634
113. Govorukhina N., Bergsma-Schutter W., Mazères-Dubut C., Mazères S., Drakopoulou E., Bystrykh L., Oling F., Mukhopadhyay A., Reviakine I., Laikee Him J., and Brisson A. In: Bandorowicz-Pikula J. (Ed). Annexins: Biological importance and annexin-related pathologies (2002), Landes Bioscience, Georgetown USA 40-58
114. Rojas E., and Pollard H.B. Membrane capacity measurements suggest a calcium-dependent insertion of synexin into phosphatidylserine bilayers. FEBS Lett. 217 1 (1987) 25-31
115. Burns A.L., Magendzo K., Shirvan A., Srivastava M., Rojas E., Alijani M.R., and Pollard H.B. Calcium channel activity of purified human synexin and structure of the human synexin gene. Proc. Natl. Acad. Sci. U. S. A. 86 10 (1989) 3798-3802
116. Langen R., Isas J.M., Hubbell W.L., and Haigler H.T. A transmembrane form of annexin XII detected by site-directed spin labeling. Proc. Natl. Acad. Sci. U. S. A. 95 24 (1998) 14060-14065
117. Isas J.M., Cartailler J.P., Sokolov Y., Patel D.R., Langen R., Luecke H., Hall J.E., and Haigler H.T. Annexins V and XII insert into bilayers at mildly acidic pH and form ion channels. Biochemistry 39 11 (2000) 3015-3022
118. Kubista H., Hawkins T.E., Patel D.R., Haigler H.T., and Moss S.E. Annexin 5 mediates a peroxide-induced Ca(2+) influx in B cells. Curr. Biol. 9 23 (1999) 1403-1406
119. Markoff A., Bogdanova N., Knop M., Rüffer C., Kenis H., Lux P., Reutelingsperger C., Todorov V., Dworniczak B., Horst J., and Gerke V. Annexin A5 interacts with polycystin-1 and interferes with the polycystin-1 stimulated recruitment of E-cadherin into adherens junctions. J. Mol. Biol. 369 4 (2007) 954-966
120. Mari C., Karabiyikoglu M., Goris M.L., Tait J.F., Yenari M.A., and Blankenberg F.G. Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radiolabeled annexin V. Eur. J. Nucl. Med. Mol. Imaging 31 5 (2004) 733-739
121. Conner S.D., and Schmid S.L. Regulated portals of entry into the cell. Nature 422 6927 (2003) 37-44
122. Brachvogel B., Dikschas J., Moch H., Welzel H., von der Mark K., Hofmann C., and Pöschl E. Annexin A5 is not essential for skeletal development. Mol. Cell. Biol. 23 8 (2003) 2907-2913